logo-loader
viewCollagen Solutions PLC

Director/PDMR Shareholding

/**/ ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .aj{size:595.3pt 841.9pt;margin:72.3pt 2.0cm 42.55pt 2.0cm;}div.aj{}p.cr{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-div: italic; line-height: normal; margin-bottom: 0cm; text-align: justify}p.cs{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: center}span.cn{color:windowtext}p.ct{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm}p.cu{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal;background:white}table.cv{width:478.8pt;margin-left:-10.8pt;border-collapse:collapse}td.cj{width:76.15pt;padding:0cm 5.4pt 0cm 5.4pt}p.cw{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-div: italic; font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify; text-decoration: underline} td.ci{width:108.2pt;padding:0cm 5.4pt 0cm 5.4pt}td.ch{width:61.25pt;padding:0cm 5.4pt 0cm 5.4pt}td.cg{width:61.2pt;padding:0cm 5.4pt 0cm 5.4pt}td.cf{width:52.7pt;padding:0cm 5.4pt 0cm 5.4pt}td.ce{width:54.5pt;padding:0cm 5.4pt 0cm 5.4pt}p.cx{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; line-height: normal; margin-bottom: 0cm; text-align: right}p.cy{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify}table.cz{margin-left:-5.4pt;border-collapse:collapse;border:none}td.bw{width:9.6pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.da{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;font-weight: bold} span.ca{font-size:11.5pt}p.db{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal}span.by{font-family:"Times New Roman","serif"}td.bu{width:407.4pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}span.bv{font-size:11.0pt;font-family:"Calibri","sans-serif"}td.bt{width:9.6pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}p.ai,li.ai,div.ai{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;}td.bs{width:143.25pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.bq{width:253.35pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.dc{margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:36.0pt;margin-bottom:.0001pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom: .0001pt;text-indent:-18.0pt;line-height:normal} p.dd{margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:36.0pt;margin-bottom:.0001pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom: .0001pt;text-indent:-18.0pt;line-height:normal}p.de{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:36.0pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom: .0001pt;text-indent:-18.0pt;line-height:normal}td.bp{width:407.4pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.df{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm}table.dg{border-collapse:collapse;border:none}tr.bl{height:27.25pt}td.bn{width:110.4pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:27.25pt}p.dh{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt; line-height:normal}td.bm{width:110.4pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:27.25pt}td.bk{width:110.4pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:27.25pt} td.bj{width:110.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:27.25pt}span.bh{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:windowtext}p.di{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}strong.be{font-div: italic}span.bf{font-family: "Calibri","sans-serif"}table.dj{width:487.15pt;margin-left:-8.25pt;border-collapse:collapse}tr.ay{height:12.35pt}td.bb{width:248.55pt; padding:0cm 5.4pt 0cm 5.4pt;height:12.35pt}p.dk{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify}td.az{width:217.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:12.35pt} p.dl{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;line-height: normal; margin-bottom: 0cm; text-align: right}td.aw{width:275.55pt; padding:0cm 5.4pt 0cm 5.4pt}p.dm{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;margin-bottom:0cm;margin-bottom:.0001pt; text-align:justify;line-height:normal}td.av{width:190.0pt;padding:0cm 5.4pt 0cm 5.4pt}td.au{width:248.55pt; padding:0cm 5.4pt 0cm 5.4pt}td.at{width:217.0pt; padding:0cm 5.4pt 0cm 5.4pt}tr.ap{height:24.45pt}td.as{width:248.55pt; padding:0cm 5.4pt 0cm 5.4pt;height:24.45pt}td.aq{width:217.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:24.45pt}span.ar{color:#00000A;text-decoration:none} p.dn{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;margin-bottom:0cm;margin-bottom:.0001pt; line-height:normal}td.ao{width:230.55pt;padding:0cm 5.4pt 0cm 5.4pt}td.an{width:235.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.am{border:none}span.ak{font-family:"Calibri","sans-serif"; font-weight:normal}p.do{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify} /**/
RNS Number : 3819B
Collagen Solutions PLC
06 June 2019
 

 

 

Collagen Solutions Plc

(the "Company")

 

Director/PDMR Dealing

 

Collagen Solutions plc (AIM:COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, is pleased to announce that, further to its announcements on 20 May 2019 and 5 June 2019 in connection with the Strategic Investment, Placing and Open Offer, the following Directors/PDMRs have acquired Shares at the Offer Price in the following amounts.

 

Director/PDMR

Position

Existing

Ordinary

Shares held

Shares

subscribed

for at Offer

Price

Aggregate price paid for Shares

Number of

Ordinary

Shares held

following

Admission

 

 

 

 

 

 

Malcolm Gillies

Non-Executive Director

4,153,000

847,000

£42,350

5,000,000

Hilary Spence

Chief Financial Officer

250,817

300,000

£15,000

550,817

Tom Hyland

Chief Operating Officer

273,847

200,000

£10,000

473,847

Gillian Black

Company Secretary

857,143

150,000

£7,500

1,007,143

 

 

 

 

 

 

 

Unless otherwise defined, capitalised terms shall have the same meaning as defined in the circular posted to Shareholders on 20 May 2019, which is available to view on the Company's website at www.collagensolutions.com   

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulations

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1.    Malcolm Gillies

2.    Hilary Spence

3.    Tom Hyland

4.    Gillian Black

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1.    Non-Executive Director

2.    Chief Financial Officer

3.    Chief Operating Officer

4.    Company Secretary

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Collagen Solutions plc

b)

 

LEI

 

 

213800IFY1CVGRGETL95

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

New ordinary shares of 1p each

 

 

ISIN: GB00B94T6Y14

 

 

 

 

b)

 

Nature of the transaction

 

 

Acquisition of new ordinary shares pursuant to placing, open offer and subscription

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1. 5p per share

 

847,000

2. 5p per share

300,000

3. 5p per share

200,000

4. 5p per share

150,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

N/A - single transactions

 

 

 

 

 

e)

 

Date of the transaction

 

 

6 June 2019

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

  

 

 

Enquiries: 

 

Collagen Solutions Plc

Contact via Walbrook

Jamal Rushdy, CEO         

 

Hilary Spence, CFO

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Giles Balleny / Stephen Keys

Tel: 0207 397 8900

 

 

 

Walbrook PR Ltd

    Tel: 020 7933 8780 or [email protected]

Anna Dunphy

Mob: 07876 741 001

       

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHCKADQFBKKCAK

Quick facts: Collagen Solutions PLC

Price: 3.55

Market: LSE
Market Cap: £15.75 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Collagen Solutions released financial number showing more...

Collagen Solutions (LON: COS) CEO Jamal Rushdy joined Steve Darling from Proactive to discuss the company releasing their financial numbers that show impressive double-digit sales growth.  Rushdy talks about the numbers and also their tissue division that continues to be a revenue driver.

3 weeks ago